Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onset of Effect of Formoterol vs Salmeterol in COPD
NCT01048333Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2010
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of formoterol in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Jan 2010; status: completed.
02
Drugs
formoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01048333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01048333.